Table 5.
Independent predictors of 1-year mortality and readmission in men.
| HR | CI 95% | p-value | |
|---|---|---|---|
| NT-proBNP (pg/ml) | 1.00 | 1.00–1.00 | <0.001 |
| Diuretic mean dose (mg of furosemide) | 1.01 | 1.01–1.02 | <0.001 |
| Frailty (FRAIL) | 1.59 | 0.86–2.95 | 0.13 |
| NT-proBNP (pg/ml) | 1.00 | 1.00–1.00 | <0.001 |
| Diuretic mean dose (mg of furosemide) | 1.01 | 1.01–1.02 | <0.001 |
| Frailty (CFS ≥4) | 1.99 | 0.95–4.14 | 0.06 |
| NT-proBNP (pg/ml) | 1.00 | 1.00–1.00 | 0.002 |
| Diuretic mean dose (mg of furosemide) | 1.01 | 1.01–1.02 | <0.001 |
| Frailty (mobility visual scale ≥2) | 2.06 | 1.05–4.04 | 0.03 |
CFS, Clinical Frailty Scale.
A Cox regression was performed for each of the different frailty scales to avoid collinearity between them: in each case, the significant variables (p < 0.001) were included in the log-rank test and the corresponding frailty scale.